C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/86 (2006.01) A61K 39/118 (2006.01) A61K 39/39 (2006.01) C07K 14/295 (2006.01) C07K 16/12 (2006.01) C12N 7/01 (2006.01) C12N 15/31 (2006.01) C12N 15/41 (2006.01) C12N 15/62 (2006.01) G01N 33/569 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2162664
Hybridpicornaviruses expressing chlamydial epitopes from the major outer membrane protein of Chlamydia trachomatis in a functional form are described. The hybrid viruses grow to high titre in cell culture and when administered to mammals induce an immune response against both the picornavirus and C. trachomatis. The antisera from immunised mammals neutralised both homotypic and heterotypic serovars of C. trachomatis. The hybrid picornaviruses have utility as vaccines and as tools for the generation of immunological reagents. Methods for modifying surface exposed loops of known sequences to produce hybrid proteins are described.
Caldwell Harlan Delano
Klein Michel Henri
Murdin Andrew David
Oomen Raymond Peter
Connaught Laboratories Limited
D.c. The Government Of The Unites States Of America As Represented By
Sim & Mcburney
LandOfFree
Hybrid picornaviruses expressing chlamydial epitopes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid picornaviruses expressing chlamydial epitopes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid picornaviruses expressing chlamydial epitopes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1949530